Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.
Versteeg L, Adhikari R, Robinson G, Lee J, Wei J, Islam N, Keegan B, Russell WK, Poveda C, Villar MJ, Jones K, Bottazzi ME, Hotez P, Tijhaar E, Pollet J.
Versteeg L, et al. Among authors: islam n.
PLoS Pathog. 2024 Dec 18;20(12):e1012764. doi: 10.1371/journal.ppat.1012764. eCollection 2024 Dec.
PLoS Pathog. 2024.
PMID: 39693359
Free PMC article.